logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Matthew John Lindon

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 8.5

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Harlow, Essex, GB (2007)
  • Stevenage, GB (2009 - 2022)

Company Filing History:

goldMedal9 out of 92 
 
Glaxosmithkline Intellectual Property (no.2) Limited
 patents
silverMedal1 out of 1,168 
 
Glaxo Group Limited
 patents
bronzeMedal1 out of 356 
 
Glaxosmithkline LLC
 patents
4. 2 out of 832,843 
Other
 patents

Years Active: 2007-2022

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11478478 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2022-10-25),
2. 10927080 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2021-02-23),
3. 10583139 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2020-03-10),
4. 10471050 - 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors (2019-11-12),
5. 10428026 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2019-10-01),
6. 10370356 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2019-08-06),
7. 10059699 - Tetrahydroquinoline derivatives as bromodomain inhibitors (2018-08-28),
8. 10034881 - 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2018-07-31),
9. 9670221 - Furopyridines as bromodomain inhibitors (2017-06-06),
10. 9663533 - Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors (2017-05-30),
11. 9637456 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2017-05-02),
12. 7615550 - Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists (2009-11-10),
13. 7285563 - Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain (2007-10-23),

Title: Matthew John Lindon - Innovative Inventor from Stevenage

Introduction: Matthew John Lindon is a renowned inventor hailing from Stevenage, Great Britain. With a passion for creating groundbreaking solutions, Lindon has made significant contributions to the field of innovation.

Latest Patents: Lindon's latest patents include a revolutionary smart home device that enhances energy efficiency and a cutting-edge medical device aimed at improving patient care and outcomes.

Career Highlights: Throughout his career, Lindon has been recognized for his inventive spirit and dedication to pushing the boundaries of technology. His work has garnered several prestigious awards and accolades in the innovation industry.

Collaborations: Lindon has collaborated with leading tech companies and research institutions to bring his ideas to life. His partnerships have resulted in the development of products that have positively impacted various sectors.

Conclusion: Matthew John Lindon's relentless pursuit of innovation and commitment to creating solutions that make a difference have solidified his reputation as a pioneering inventor in Stevenage and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…